Literature DB >> 22240891

Variants of endothelial nitric oxide synthase gene are associated with components of metabolic syndrome in an Arab population.

Khalid M Alkharfy1, Nasser M Al-Daghri, Omar S Al-Attas, Majed S Alokail, Abdul Khader Mohammed, Benjamin Vinodson, Mario Clerici, Usamah Kazmi, Tajamul Hussain, Hossam M Draz.   

Abstract

Genetics plays a crucial role in the development of metabolic syndrome (MetS). Here we examined the association between endothelial nitric oxide synthase (eNOS) gene polymorphisms and MetS in a Saudi Arabian cohort to extend the understanding of the genetic basis of MetS in diverse ethnic populations. Anthropometric, clinical and biochemical parameters as well as genotyping for 894G>T, -786T>C variants of eNOS gene by PCR-RFLP and 4a/b by direct PCR were performed in 886 Saudi Arabians (477 MetS and 409 Non-MetS). The genotype distribution (TT, p=0.001; TC, p=0.001; TC+CC, p=0.001) and allele (T, p=0.007; C, p=0.007) frequency of the -786T>C SNP were significantly different between Non-MetS and MetS subjects which remained significant after Bonferroni correction. Moreover: 1) the GT and GT+TT genotypes of the 894G>T SNP were associated with elevated blood pressure (p=0.017, and p=0.022, respectively); 2) the ab variant of 4a/b polymorphism was associated with decreased HDL levels (p= 0.044); and 3) the TC+CC genotype and C allele of the -786T>C SNP were associated with increased fasting glucose levels (p=0.039, and p=0.028, respectively). Also, G-a-C was identified as the risk haplotype for MetS susceptibility (p=0.034). The results suggest a significant association of 894G>T, 4a/b and -786T>C polymorphisms with MetS and its components is present in an Arab population. A genetic predisposition to develop abnormal metabolic phenotypes, consistent with an increased prevalence of metabolic phenotypes can be detected in this ethnic group.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22240891     DOI: 10.1507/endocrj.ej11-0278

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  7 in total

1.  Metabolic syndrome is negatively associated with cognition among endothelial nitric oxide synthase (eNOS)- 786C carriers in schizophrenia-spectrum disorders.

Authors:  A Zarina Kraal; Allison C Moll; Nicole R Arvanitis; Kristen M Ward; Ryan J Dougherty; Tyler B Grove; Kyle J Burghardt; Vicki L Ellingrod
Journal:  J Psychiatr Res       Date:  2019-07-26       Impact factor: 4.791

2.  eNOS polymorphism associated with metabolic syndrome in children and adolescents.

Authors:  Josiane A Miranda; Vanessa A Belo; Débora C Souza-Costa; Carla M M Lanna; Jose E Tanus-Santos
Journal:  Mol Cell Biochem       Date:  2012-09-15       Impact factor: 3.396

3.  Association of endothelial nitric oxide synthase (eNOS) gene G894T polymorphism with hypertension risk and complications.

Authors:  Abeer A ALrefai; Mona Salah El-Din Habib; Rehab I Yaseen; Mahmoud K Gabr; Rabab M Habeeb
Journal:  Mol Cell Biochem       Date:  2016-08-24       Impact factor: 3.396

4.  Genetic Variants of the PLCXD3 Gene Are Associated with Risk of Metabolic Syndrome in the Emirati Population.

Authors:  Hayat Aljaibeji; Abdul Khader Mohammed; Sami Alkayyali; Mahmood Yaseen Hachim; Hind Hasswan; Waseem El-Huneidi; Jalal Taneera; Nabil Sulaiman
Journal:  Genes (Basel)       Date:  2020-06-18       Impact factor: 4.096

5.  Gene-environment interactions in human health: case studies and strategies for developing new paradigms and research methodologies.

Authors:  Fatimah L C Jackson
Journal:  Front Genet       Date:  2014-08-29       Impact factor: 4.599

6.  Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and metabolic syndrome in healthy subjects and schizophrenia patients.

Authors:  Nikolai Fattakhov; Liudmila Smirnova; Dmitriy Atochin; Daria Parshukova; Daria Skuratovskaia; Quinn Painter; Pavel Zatolokin; Arkadiy Semke; Larisa Litvinova; Svetlana Ivanova
Journal:  Int J Obes (Lond)       Date:  2018-06-15       Impact factor: 5.095

Review 7.  Does eNOS derived nitric oxide protect the young from severe COVID-19 complications?

Authors:  Shou Ping Guan; Raymond Chee Seong Seet; Brian K Kennedy
Journal:  Ageing Res Rev       Date:  2020-11-04       Impact factor: 10.895

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.